title: Which bisphosphonate to treat bone metastases?
authors: Oncology Division, Hospital de Santa Maria, Instituto de Medicina Molecular, University of Lisbon, 1649-035 Lisbon, Portugal. Electronic address: luiscosta.oncology@gmail.com.
authors: Luis
authors: L
authors: Costa
mesh_terms: D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D001943:Breast Neoplasms / Q000473:pathology*; D004164:Diphosphonates / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D000077557:Ibandronic Acid; D007093:Imidazoles / Q000008:administration & dosage*; D008297:Male; D000077211:Zoledronic Acid
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid; D000077557:Ibandronic Acid